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Abstract
Bacteroides fragilis and related species are important human pathogens involved in mixed infections of different origins. The B. fragilis
group isolates are phenotypically very similar, grow more slowly than aerobic bacteria and, accordingly, are frequently misidentifed with
classical or automated phenotypical identiﬁcation methods. Recent taxonomic changes and new species accepted as members of the
Bacteroides genus are not included in the different databases of commercially available identiﬁcation kits. The use of matrix-assisted
laser-desorption/ionization time-of-ﬂight mass spectrometry (MALDI-TOF MS) was therefore evaluated for the species identiﬁcation of
277 clinical isolates of the Bacteroides genus. Species identiﬁcation was carried out with MALDI Bruker Daltonik Biotyper software (Bru-
ker Daltonik GmbH, Bremen, Germany) by comparing the mass spectrum of each strain with the mass spectra of the 3260 reference
strains currently available. The results of conventional phenotypical identiﬁcation of the isolates were used as a reference. 16S rRNA
gene sequencing was performed for a selection of the strains that gave discrepant results and for all those inconclusively identiﬁed by
MALDI-TOF MS; 270 isolates (97.5%) were unequivocally identiﬁed [log(score) ‡2.0] by comparison with the reference strains present
in the MALDI Biotyper database. Of the 23 isolates for which the MALDI-TOF MS species identiﬁcation differed from the conventional
phenotypical identiﬁcation, 11 were sequenced. The sequencing data conﬁrmed the MALDI-TOF MS result in ten cases and, for the
remaining isolate, the sequencing data did not lead to the determination of the species, but only to that of the genus (Bacteroides sp.).
The discriminating power and identiﬁcation accuracy of MALDI-TOF MS proved to be superior to that of biochemical testing for Bacte-
roides thetaiotaomicron, Bacteroides ovatus and Bacteroides uniformis.
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Introduction
Bacteroides fragilis and related species are important compo-
nents of the commensal ﬂora in the lower intestinal tract of
mammals, but are also important and frequently isolated as
opportunistic anaerobic pathogens causing severe infections,
including intra-abdominal, pelvic, lung and brain abscesses,
peritonitis and sepsis [1]. Bacteraemia due to B. fragilis group
isolates contributes appreciably to morbidity and mortality
[1–3]. Infections caused by Bacteroides strains, alone or in
mixed cultures, are especially signiﬁcant because they exhibit
resistance mechanisms to almost all groups of antibiotics and
the level of resistance to some antibiotics may be extremely
high [4]. Resistance to the most potent antibiotics, such as
carbapenems, beta-lactam and beta-lactamase inhibitor combi-
nations and fourth-generation ﬂuoroquinolones, has slowly
increased in Europe over the past 15 years [5,6]. Correct
identiﬁcation at the species level is necessary because the
resistance to different anti-anaerobic drugs may differ
according to the species [7]. Presumptive identiﬁcation may
be performed with antibiotic discs and spot tests (Wads-
worth method) [8]; for example, at the genus level (Bactero-
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ides fragilis group). Deﬁnitive species-level identiﬁcation
requires a battery of biochemical tests, low molecular weight
fatty acid proﬁling and, occasionally, molecular genetic meth-
ods, such as 16S rRNA gene sequencing. Routine laborato-
ries can identify Bacteroides isolates using different substrates
in a conventional manner or via commercially available identi-
ﬁcation kits that require a shorter incubation period in an
aerobic environment (i.e. detection of preformed enzymes)
or a longer incubation in an anaerobic environment (i.e.
detection of inducible enzymes). However, these phenotypic
methods do not always clearly distinguish closely related spe-
cies and deﬁnitive identiﬁcation requires a lengthy incubation
after isolation of these bacteria from clinical specimens.
The taxonomy of Bacteroides has undergone signiﬁcant
changes in recent years [9]. The presumed genus Bactero-
ides was found to contain species from several genera.
Most of the species previously included among the Bactero-
ides were placed into two new genera, Porphyromonas and
Prevotella [9], but other genera have subsequently been
described for further species that do not belong in these
three major groups (e.g. Anaerorhabdus, Dichelobacter, Dialis-
ter, Fibrobacter, Megamonas, Mitsuokella, Rikenella, Sebaldella,
Tannerella, Tissierella and Alistipes) [8]. The new Bacteroides
spp. Bacteroides nordii and Bacteroides salyersae, found in
clinical specimens [10], can be misidentiﬁed as Bacteroides
stercoris and Bacteroides uniformis with routine biochemical
tests. The recently described Bacteroides goldsteinii was phy-
logenetically close to Bacteroides distasonis and Bacteroides
merdae as classiﬁed by 16S rRNA gene sequencing [11].
However, these latter three species were recently reclassi-
ﬁed as Parabacteroides, Parabacteroides distasonis, Parabactero-
ides merdae and Parabacteroides goldsteinii; they are
phenotypically similar to members of the Bacteroides genus
(senso stricto) but are distinct phylogenetically [12].
Matrix-assisted laser-desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS) has been shown to
constitute a useful and simple method for the rapid
identiﬁcation of microorganisms associated with infectious
diseases and also for discriminating between different
subtypes of pathogens [13–15]. The present study aimed to
set up a database for the most frequently isolated anaerobic
Bacteroides spp. and to test the applicability of MALDI-TOF
MS proﬁling for the identiﬁcation of Bacteroides spp.
Materials and Methods
Isolates
The 277 clinical isolates analysed in the present study were
collected during a Europe-wide antibiotic resistance
surveillance of Bacteroides spp, the results of which will be
published soon.
Their identiﬁcation was performed in the collecting labo-
ratories with different phenotypical methods, such as classical
biochemical tests, rapid ID 32A (ATB) and API20 ANA (bio-
Me´rieux SA, Marcy-l’Etoile, France). In some cases, only
genus-level identiﬁcation was available. Because identiﬁcation
at the species level may be important for the evaluation of
differences in antibiotic resistance of Bacteroides strains, the
central laboratory (Szeged) re-identiﬁed all strains received
for the study. Part of the present work involved parallel clas-
sical biochemical tests [8] and analysis with MALDI Biotyper
software. All strains were cultured on Columbia agar base
(Oxoid, Basingstoke, UK) supplemented with 5% (v/v) cattle
blood, haemin (1 mg/L) and vitamin K1 (5 mg/L) for 24–48 h
at 37C in an anaerobic chamber (Bactron from Sheldon
Manufacturing Inc., Cornelius, OR, USA). Cryobank vials
(Mast Diagnostics, Reinfeld, Germany) were used for long-
term strain storage. ATCC 25285 B. fragilis, DSM2151 B. fragi-
lis and ATCC 29742 Bacteroides thetaiotaomicron were used
as control strains.
Sample preparation for MALDI-TOF MS measurement
One colony of each bacterial strain that had been subcul-
tured for 24 h was transferred into an Eppendorf vial and
carefully suspended in 300 lL of bidistilled water. Ethanol
(900 lL) was added to the suspension and mixed well. At
this stage, the stabilized samples were sent from the Szeged
reference laboratory to the Bruker laboratory in Leipzig.
There, the samples were centrifuged (13 000 g for 2 min),
the supernatants were removed and the pellets were dried
at room temperature. Each bacterial pellet was re-suspended
in 50 lL of 70% aqueous formic acid and 50 lL of acetoni-
trile. After centrifugation (13 000 g for 2 min), 1 lL of the
supernatant was spotted onto a sample position on a
ground-steel MALDI target plate and dried at room tempera-
ture. Subsequently, a further 2-lL aliquot of MALDI matrix
(a saturated solution of HCCA (a-cyano-4-hydroxycinnamic
acid) in 50% acetonitrile/2.5% triﬂuoro-acetic acid) was
added to the spot, which was again dried. The MALDI target
plate was subsequently introduced into the MALDI-TOF
mass spectrometer for automated measurement and data
interpretation.
Instrumentation and data acquisition
Samples were analysed with a microﬂex LT or ultraﬂex
TOF/TOF MALDI-TOF instrument (Bruker Daltonik GmbH,
Bremen, Germany). Spectra were acquired in the linear,
positive ion mode with a laser frequency of 20 Hz (micro-
ﬂex) or 200 Hz (ultraﬂex). Parameter settings for microﬂex
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LT were: IS1 20 kV, IS2 18.5 kV, lens 8.5 kV, PIE 250 ns, no
gating; and for ultraﬂex: IS1 20 kV, IS2 18.75 kV, lens
5.75 kV, PIE 350 ns, gating 1250 Da.
Data processing with MALDI Biotyper software
Recorded mass spectra were processed with the MALDI
Biotyper 2.0 software package, using the standard settings.
Spectra were smoothed and baseline corrected, and peak
masses were determined and transferred to a list of up to
70 peak masses. For the construction of new database
entries, several (up to 20) mass spectra were processed
with the software functionality and standard settings. The
spectral peak lists for a particular strain were transferred
into a main spectrum (MSP) containing information on aver-
age peak masses, average peak intensities and peak
frequencies.
Identiﬁcation of clinical isolates
The peak lists derived from the bacterial MALDI-TOF pro-
ﬁle mass spectra were compared with each entry of the
MALDI Biotyper database, currently containing 3260 refer-
ences, using the standard parameters of the pattern-match-
ing algorithm. The MALDI Biotyper output is a log(score)
in the range 0–3.0, computed by comparison of the peak
list for an unknown isolate with the reference MSP in the
database. A log(score) ‡1.7 is indicative of a close rela-
tionship (i.e. at the genus level) and a log(score) of ‡2.0 is
the set threshold for a match at the species level.
16S rRNA gene sequencing for discrepant isolates
For ampliﬁcation of the 16S rRNA gene fragment, the
unique universal primers E8F and E533R [16] were used.
Sequencing was achieved with the ABI Prism BigDye Termi-
nator Cycle Sequencing Ready Reaction Kit, version 3.1 and
the ABI Prism 3100 Genetic Analyser (Applied Biosystems,
Foster City, CA, USA). The sequence data for the 16S
rRNA genes were compared with those of the GenBank
database using BLAST software (http://www.ncbi.nlm.nih.
gov/blast/cgi). A homology level >98% was considered
adequate for species identiﬁcation.
Results
Two hundred and seventy-seven clinical Bacteroides isolates
were selected from a European strain collection to be
tested by a MALDI-TOF MS method for species identiﬁca-
tion, in comparison with a classical phenotypical species
determination. Two hundred and seventy of the 277 iso-
lates were unequivocally identiﬁed [log(score) ‡2.0] by
comparison with the reference strains present in the
MALDI Biotyper database (Table 1). For seven isolates,
identiﬁcation was inconclusive because of the lack of an
appropriate reference in the database [log(score) <1.7]. All
seven of these isolates were therefore selected for 16S
rRNA gene sequencing. The sequencing data conﬁrmed
the biochemical identiﬁcation of P. (B.) distasonis in three
cases (Table 2). One of these strains was subsequently
prepared in two parallels for MALDI-TOF MS and 20
spectra were acquired, transferred into the main spectrum
and added to the database of the MALDI Biotyper data-
base. The three other isolates, which could not be identi-
ﬁed according to their spectra, and which belonged to
P. (B) distasonis and B. thetaiotaomicron according to the con-
ventional biochemical tests, gave a log(score) >2.5 for
these species (Table 2). The other three strains proved to
be Bacteroides eggerthii, P. (B.) goldsteinii and B. intestinalis. The
spectra of two type strains of B. fragilis (B. fragilis ATCC
25285 grown in Szeged and B. fragilis DSM 2151 grown in
Leipzig) were compared. Comparatively, identiﬁcation led to
a highly signiﬁcant log(score) of 2.5, demonstrating the
reproducibility of the method even if the culture conditions
were not identical.
One potential advantage of the MALDI method is the
rapid and simple differentiation of subtypes of different spe-
cies. For the B. fragilis strains, several MS peaks may be used
for subtyping (Fig. 1). The peak masses that may discriminate
different B. fragilis isolates are 8776 and 8907 Da for the ﬁrst
group, 8788 and 8919 Da for the second group, and 8808
and 8941 Da for the third group of strains. The differentiat-
ing features were reproducible in multiple measurements.
Newly accepted species, for example B. salyersae and B. nordii,
TABLE 1. Species determination of 277 clinical isolates of
Bacteroides by MALDI-TOF MS
Species
Number of isolates
With an
identiﬁcation
score ‡2.0 by
MALDI-TOF
MS
With discrepant
species
identiﬁcation
by biochemical
tests
Selected
for 16S
rRNA gene
sequencing
a
B. fragilis 179 5 2
B. thetaiotaomicron 43 5 4
B. ovatus 15 6 1
B. vulgatus 20 1 1
B. uniformis 5 3 2
B. eggerthii 1 0
B. nordii 4 3 1
B. salyersiae 1 0
B. massiliensis 2 0
Inconclusive identiﬁcation
by MALDI-TOF MS
7 7
aOnly strains with a MALDI-TOF MS score of 2.0–2.5 and those inconclusively
identiﬁed were selected for sequencing.
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could be identiﬁed by MALDI-TOF MS (Table 1). Clear dif-
ferentiation was achieved for the different human pathogenic
Bacteroides isolates (Fig. 2).
Of the 270 isolates unequivocally identiﬁed by MALDI-
TOF MS, 23 gave a discrepant result using classical bio-
chemical identiﬁcation (Table 1). Eleven of the 23 isolates
that had a log(score) of 2.0–2.5 by MALDI-TOF MS were
selected for 16S rRNA gene sequencing (Table 2). The
sequencing data conﬁrmed the MALDI-TOF MS ﬁnding for
ten isolates but, in one case, which was identiﬁed by
MALDI-TOF MS as B. vulgatus with a log(score) 2.017 (sam-
ple number 8), the sequencing data did not lead to a spe-
cies determination, but ended at the genus level (a new
Bacteroides sp.) showing a relationship with B. uniformis, B. eg-
gerthii and B. thetaiotaomicron. The discriminatory power and
identiﬁcation accuracy of MALDI-TOF MS was superior to
biochemical testing in the cases of B. thetaiotaomicron,
B. ovatus and B. uniformis.
Discussion
The important role of anaerobic bacteria in a variety of
human infections has been accepted ever since the 1960s
[1]. B. fragilis group strains are the most common agents
in infections caused by anaerobic Gram-negative bacilli
TABLE 2. Results of 16S rRNA
sequencing of selected strains
which gave discrepant results by
MALDI-TOF MS and biochemical
testing and inconclusive
identiﬁcation with the MALDI
Biotyper
Sample
number
Species determined by
Biochemical tests MALDI-TOF MS 16S rRNA gene sequencing
1 Bacteroides ovatus Bacteroides fragilis Bacteroides fragilis
2 Bacteroides uniformis Bacteroides fragilis Bacteroides fragilis
3 Bacteroides ovatus Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron
4 Bacteroides uniformis Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron
5 Bacteroides uniformis Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron
6 Bacteroides ovatus Bacteroides thetaiotaomicron Bacteroides thetaiotaomicron
7 Bacteroides uniformis Bacteroides ovatus Bacteroides ovatus
8 Bacteroides thetaiotaomicron Bacteroides vulgatus Bacteroides sp. (new?)
9 Bacteroides ovatus Bacteroides uniformis Bacteroides uniformis
10 Bacteroides ovatus Bacteroides uniformis Bacteroides uniformis
11 Bacteroides ovatus Bacteroides nordii Bacteroides nordii
12 Bacteroides thetaiotaomicron II (log(score) >2.5)a Parabacteroides (B.) distasonis
13 Parabacteroides (B.) distasonis II Parabacteroides (B.) distasonis
14 Parabacteroides (B.) distasonis II (log(score) >2.5) Parabacteroides (B.) distasonis
15 Parabacteroides (B.) distasonis II (log(score) >2.5) Parabacteroides (B.) distasonis
16 Bacteroides thetaiotaomicron II Bacteroides eggerthii
17 Bacteroides merdae II Bacteroides goldsteinii
18 Bacteroides sp. II Bacteroides intestinalis
II, inconclusive identiﬁcation.
aAchieved log(score) by MALDI-TOF MS analysis after adding to the data base the MS of the sequenced P. (B.)
distasonis (13).
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FIG. 1. Example of shifts distinguishing
the Bacteroides fragilis strains in three
subgroups.
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[2,17–20]. The different species in the B. fragilis group are
phenotypically very similar. The automated methods used
routinely in laboratories for the identiﬁcation of Bacteroides
strains are not always sufﬁciently discriminating, and may be
highly inﬂuenced by the level of anaerobiosis during incuba-
tion; in addition, their databases do not contain all
accepted, newly-recognized species. Compared with con-
ventional methods, rapid identiﬁcation with preformed
enzyme kits, without additional tests, gives a correct identi-
ﬁcation in only 78–79% of the B. fragilis group strains
[21,22]. Direct sequencing of PCR-ampliﬁed bacterial 16S
rDNA is a relatively new molecular method. It is faster
than the conventional phenotypical method but is seldom
used by clinical microbiology laboratories for species identi-
ﬁcation on a routine basis.
To overcome the problems of inconclusive species identi-
ﬁcation with phenotypical methods and the lack of sequen-
cing facilities in many routine laboratories, MALDI-TOF MS
was evaluated for identiﬁcation of Bacteroides spp. This tech-
nique initially unequivocally identiﬁed 97.5% of the strains
tested (270 of the 277). The rate increased to 98.6% when
the mass spectrum of a clinical isolate proven by sequencing
data to be P. (B.) distasonis was added to the MALDI Biotyper
database. This database currently does not contain the mass
spectra of all possible human pathogenic anaerobic bacteria;
species not represented in the database include some of
the B. fragilis group strains, or species earlier classiﬁed as
Bacteroides, but later moved to other genera. However, the
possibility of extending the database with the mass spectra
of further reference strains, or sequenced clinical isolates,
will improve the identiﬁcation capacity of the method still
further. In the present study, 8.5% of the strains (23/270),
with a high MALDI log(score) for species identiﬁcation gave
a different species determination compared to conventional
biochemical testing. The majority (n = 14) of these strains
were identiﬁed biochemically as B. ovatus, B. thetaiotaomicron
and B. uniformis. Using 16S rRNA gene sequencing for species
identiﬁcation of B. thetaiotaomicron, Teng et al. [23] found
that some isolates of this species, previously identiﬁed phe-
notypically, proved to be B. ovatus or B. distasonis from the
sequencing data. Conversely, B. uniformis and B. caccae were
re-identiﬁed as B. thetaiotaomicron. In all cases where
FIG. 2. Mass spectra of type strains of six different Bacteroides species.
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sequencing was performed on such species in the present
study, the sequencing data revealed that MALDI-TOF MS
was superior to biochemical testing for species identiﬁcation
(Table 2). B. nordii is a newly accepted species of clinical
importance. Altogether, four isolates were identiﬁed as B. nor-
dii by MALDI-TOF MS. Of these four isolates, only one was
correctly identiﬁed by the original laboratory using pheno-
typical methods, two were identiﬁed only as Bacteroides sp.,
and one as B. ovatus. The sequencing of this latter isolate
demonstrates the superiority of MALDI-TOF MS relative to
biochemical identiﬁcation for the species determination of
this infrequently isolated Bacteroides species.
MALDI-TOF MS has previously been shown to be suitable
for the subtyping of different species [14]. The mass spectra
of Listeria strains allow their identiﬁcation at the species level
and the differentiation of pathogenic L. monocytogenes strains
at the level of clonal lineages [24]. For B. fragilis isolates, the
subtyping potential is obvious, but must be explored in detail
in future studies (Fig. 1).
A major problem in anaerobic bacteriology is the special
incubation environment needed for isolation and, in most
cases, for the biochemical identiﬁcation of anaerobic bacteria,
which demands a lengthier procedure than for aerobic
pathogens. MALDI-TOF MS using the database of the MALDI
Biotyper requires only 10 min from starting the preparation
by picking a colony, to species identiﬁcation.
Processing 96 samples takes less than 3 h [13] and the cost
is minimal. The protocol for sample preparation is simple and
can be used for other anaerobes such as Fusobacterium and
Prevotella (data not shown). A collection of Clostridium strains
pathogenic to animals and humans was recently investigated;
64 strains belonging to 31 different species were identiﬁed
correctly by MALDI-TOF MS with good discriminatory power,
even for Clostridium species, which are normally difﬁcult to dif-
ferentiate using traditional methods [15].
In summary, the MALDI-TOF MS method provided accu-
rate and fast species identiﬁcation for the most frequently
isolated human pathogenic anaerobic bacteria (i.e. members
of the genus Bacteroides), with good discriminatory power
for closely related species. Extension of the database to
include other anaerobic bacteria of clinical importance will
enhance the value of this methodology in routine clinical
microbiology laboratories for species identiﬁcation of anaer-
obic bacteria.
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